📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Ethris

1.1 - Company Overview

Ethris Logo

Ethris

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of mRNA therapeutics and LNP delivery solutions focused on respiratory diseases and vaccines. Offers the SNIM RNA platform for stabilized non-immunogenic mRNA therapies and the SNaP LNP platform for targeted, inhalable delivery. Pipeline includes ETH47, ETH42, and ETH45 for respiratory indications. Provides in-house and partnered manufacturing with HPLC-free processes.

Products and services

  • SNaP LNP platform: Lipidoid nanoparticle system optimized to transport mRNA therapies efficiently to target cells, including via inhalation for respiratory tract targeting, enabling precise delivery
  • SNIM® RNA platform: First-in-class technology creating stabilized non-immunogenic mRNA therapies that, upon administration, produce therapeutic proteins in vivo, offering an alternative to recombinant protein or gene therapies
  • Manufacturing capabilities: In-house and partnered processes fabricate high-quality mRNA therapeutics, including HPLC-free upstream and downstream processes

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Ethris

Strata Oncology Logo

Strata Oncology

HQ: United States Website
  • Description: Provider of precision oncology solutions, including Strata Select, a DNA/RNA-based molecular profiling test guiding immunotherapy and other treatment selection for advanced cancer; the Immunotherapy Response Score predicting benefit of anti-PD-1/PD-L1 monotherapy; and clinical trials such as Strata PATH and Strata Trial enabling biomarker-guided evaluation and access to approved and investigational therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Strata Oncology company profile →
Avrobio Logo

Avrobio

HQ: United States Website
  • Description: Provider of clinical-stage cell and gene therapies under development targeting cancer and rare disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avrobio company profile →
Firefly BioWorks Logo

Firefly BioWorks

HQ: United States Website
  • Description: Provider of an open platform that enables industrial, academic, and clinical scientists to develop and use multiplexed biological assays on standard laboratory instrumentation, leveraging its core Optical Liquid Stamping technology developed in MIT’s Chemical Engineering Department.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Firefly BioWorks company profile →
Bioline Logo

Bioline

HQ: United Kingdom Website
  • Description: Provider of fast, easy-to-use, guaranteed-to-work products developed by scientists to help customers focus on their scientific goals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bioline company profile →
MIDI Logo

MIDI

HQ: United States Website
  • Description: Provider of chemical analysis and microbial identification solutions for agriculture and environmental microbiology laboratories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MIDI company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Ethris

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Ethris

2.2 - Growth funds investing in similar companies to Ethris

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Ethris

4.2 - Public trading comparable groups for Ethris

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Ethris

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Ethris

What does Ethris do?

Ethris is a provider of mRNA therapeutics and LNP delivery solutions focused on respiratory diseases and vaccines. Offers the SNIM RNA platform for stabilized non-immunogenic mRNA therapies and the SNaP LNP platform for targeted, inhalable delivery. Pipeline includes ETH47, ETH42, and ETH45 for respiratory indications. Provides in-house and partnered manufacturing with HPLC-free processes.

Who are Ethris's competitors?

Ethris's competitors and similar companies include Strata Oncology, Avrobio, Firefly BioWorks, Bioline, and MIDI.

Where is Ethris headquartered?

Ethris is headquartered in Germany.

How many employees does Ethris have?

Ethris has 1,000 employees 🔒.

When was Ethris founded?

Ethris was founded in 2010 🔒.

What sector and industry vertical is Ethris in?

Ethris is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Ethris

Who are the top strategic acquirers in Ethris's sector and industry

Top strategic M&A buyers and acquirers in Ethris's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Ethris?

Top strategic M&A buyers groups and sectors for Ethris include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Ethris's sector and industry vertical

Which are the top PE firms investing in Ethris's sector and industry vertical?

Top PE firms investing in Ethris's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Ethris's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Ethris's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Ethris's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Ethris include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Ethris's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Ethris?

The key public trading comparables and valuation benchmarks for Ethris include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Ethris for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Ethris with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Ethris's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Ethris with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Ethris's' sector and industry vertical?

Access recent funding rounds and capital raises in Ethris's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Ethris